Li J J, Talley D J, Li S A, Villee C A
Cancer Res. 1976 Mar;36(3):1127-32.
Linear sucrose gradient analyses reveal that all estrogen-induced and -dependent primary renal tumor cytosols examined contain an 8 S and variable amounts of 4 S receptor in low ionic buffer concentrations. Similar results were obtained with extracts of primary metastases of these tumors. Sucrose gradients containing high salt (0.4 M KCl) convert the 8 S receptor in both the hamster renal tumor and uterus to a 4 to 5 S complex. Scatchard plot analysis reveals that the renal tumor cytosol estradiol-receptor complex has a Ka of 1.7 X 10(9) M-1 and 9.2 X 10(-10) M binding sites. Competition for the tritiated 17beta-estradiol binding sites in the renal tumor was similar to that in the uterus with respect to estrogenic compounds. Nonestrogenic steroids exhibited minimal competition at the same concentrations or higher. Substitution in the ring structure, particularly in position 3 of the phenolic A-ring, resulted in a considerable loss in the ability of such compounds to compete for these receptors. Aniestrogens were effective competitors for these estrogen receptors only at higher concentrations relative to the tritiated estradiol.
线性蔗糖梯度分析显示,在低离子缓冲液浓度下,所有经检测的雌激素诱导和依赖的原发性肾肿瘤细胞溶质均含有一个8S受体以及不同量的4S受体。这些肿瘤的原发性转移灶提取物也得到了类似结果。含有高盐(0.4M KCl)的蔗糖梯度可将仓鼠肾肿瘤和子宫中的8S受体转化为4至5S复合物。Scatchard作图分析表明,肾肿瘤细胞溶质雌二醇受体复合物的解离常数(Ka)为1.7×10⁹ M⁻¹,结合位点为9.2×10⁻¹⁰ M。就雌激素化合物而言,肾肿瘤中氚标记的17β-雌二醇结合位点的竞争情况与子宫中的相似。在相同浓度或更高浓度下,非雌激素类甾体的竞争作用极小。环结构的取代,尤其是酚A环3位的取代,会导致此类化合物竞争这些受体的能力大幅丧失。抗雌激素仅在相对于氚标记雌二醇更高的浓度下才是这些雌激素受体的有效竞争者。